article thumbnail

Provision of care in clinical cardiac electrophysiology during and after the COVID-19 pandemic: an open challenge for health care systems

HeartRhythm

The outbreak of COVID-19 pandemic was first reported in China between December 2019 and January 2020 and then spread to Europe, with Italy among the first countries with recognized clusters. The COVID-19 pandemic turned everyone’s life upside down and the end of the emergency was declared by WHO only on May 5, 2023.

article thumbnail

COVID-19 myocarditis illusions

Dr. Anish Koka

I’m a cardiologist, and the first disconnect that became glaringly obvious very quickly was the impact COVID was having on the heart. As I walked through COVID rooms in the Spring of 2020 trying to hold my breath, I waited for a COVID cardiac tsunami. There never was a cardiac tsunami from COVID. But it got worse.

article thumbnail

A systematic review and meta?analysis of new?onset atrial fibrillation in the context of COVID?19 infection

Journal of Cardiovascular Electrophysiology

Abstract New-onset atrial fibrillation (NOAF) in COVID-19 raises significant clinical and public health issues. This systematic review and meta-analysis aims to compile and analyze the current literature on NOAF in COVID-19 and give a more comprehensive understanding of the prevalence and outcomes of NOAF in COVID-19.

article thumbnail

Abstract 239: Effects of the COVID?19 Pandemic on Stroke Treatment in Australia

Stroke: Vascular and Interventional Neurology

Although Australia has been known to offer excellent stroke treatment and care services in recent years (Deloitte Access Economics, 2020), the rise of the COVID19 pandemic caused a reduction in resource availability and delays in stroke treatment.

article thumbnail

Abstract 58: Socioeconomically Driven Reversal of Mortality Trends Among Patients With Primary Intracerebral Hemorrhage During the COVID-19 Pandemic: An Analysis of Nationally Representative Data

Stroke Journal

Background:Nationwide data demonstrating the impact of the COVID-19 pandemic on hemorrhagic stroke outcomes are lacking.Methods:We used the National Inpatient Sample (2016-2020) to identify adults (>=18 years) with primary intracerebral hemorrhage (ICH) or subarachnoid hemorrhage (SAH). 2.51; SAH: 2.76, 1.68-4.54),

article thumbnail

Cardiology update: Should mRNA vaccine myocarditis be a contraindication to future COVID-19 vaccinations ?

Dr. Anish Koka

Myopericarditis is a now a well reported complication associated with Sars-Cov-2 (COVID-19) vaccinations. To add insult to injury, he contracted COVID 2 months after the second episode of pericarditis, but had no recurrence of the symptoms of pericarditis. The tragedy here is that this wasn’t a surprise.

article thumbnail

Post-pandemic, US cardiovascular death rate continues upward trajectory

Medical Xpress - Cardiology

New research confirms what public health leaders have been fearing: The significant uptick in the cardiovascular disease (CVD) death rate that began in 2020 has continued.